Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 517

Results For "CHI"

5475 News Found

Global Health files DRHP for over Rs 500 crore issue
News | October 01, 2021

Global Health files DRHP for over Rs 500 crore issue

Global Health operates a network of four hospitals under the Medanta brand in Gurugram, Indore, Ranchi and Lucknow. In addition, one hospital is under construction in Patna, and another is planned for development in Noida


L&T Technology Services (LTTS), collaborates with Intel for Chest rAI solution
Digitisation | October 01, 2021

L&T Technology Services (LTTS), collaborates with Intel for Chest rAI solution

The AI-infused solution enables radiologists by fast triaging abnormalities in X-ray, annotating and automatic report generation with significantly improved performance


Jubilant concludes pre-IND meeting of JB1-802 with U.S. FDA
Biotech | October 01, 2021

Jubilant concludes pre-IND meeting of JB1-802 with U.S. FDA

The company plans to submit the IND application by the end of 2021


Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy
Biotech | October 01, 2021

Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy

Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval


Merck to acquire Acceleron for US $ 11.5 billion
News | October 01, 2021

Merck to acquire Acceleron for US $ 11.5 billion

The acquisition complements and strengthens Merck’s cardiovascular pipeline


Merck and Ridgeback’s molnupiravir offer hope to Covid-19 patients
Biotech | October 01, 2021

Merck and Ridgeback’s molnupiravir offer hope to Covid-19 patients

If cleared, Merck's drug would be the first pill shown to treat Covid-19, a potentially major advance in efforts to fight the pandemic


WHO new Essential Medicines Lists focus on diabetes and cancer
Public Health | September 30, 2021

WHO new Essential Medicines Lists focus on diabetes and cancer

The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all


Glenmark receives marketing approval for Ryaltris in 13 countries across the EU and UK
Drug Approval | September 30, 2021

Glenmark receives marketing approval for Ryaltris in 13 countries across the EU and UK

Ryaltris is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis


UFlex partners with Hoffer Plastics and Mespack to launch recyclable mono-polymer hot fill pouches
Packaging | September 30, 2021

UFlex partners with Hoffer Plastics and Mespack to launch recyclable mono-polymer hot fill pouches

These pouches, manufactured at UFlex India plant, will be exported to American markets and will be majorly used for packing edible products


Apollo Hospitals dedicates AI tool to predict cardiovascular disease to the nation
Hospitals | September 29, 2021

Apollo Hospitals dedicates AI tool to predict cardiovascular disease to the nation

Cardiovascular disease is the leading cause of death in the Asia Pacific, and it's a problem that will only intensify as populations continue to age